Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology by Ethun, Cecilia G., Bilen, Mehmet A., Jani, Ashesh B., Maithel, Shishir K., Ogan, Kenneth, Master, Viraj A.

Request full text

Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma by McGregor, Bradley A., Lalani, Aly-Khan A., Xie, Wanling, Steinharter, John A., E. Bakouny, Ziad, Martini, Dylan J., Fleischer, Justin H., Abou-Alaiwi, Sarah, Nassar, Amin, Nuzzo, Pier V., Kaymakcalan, Marina D., Braun, David A., Wei, Xiao X., Harshman, Lauren C., Bilen, Mehmet A., Choueiri, Toni K.

Get full text

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA by Agarwal, Neeraj, Pal, Sumanta K., Hahn, Andrew W., Nussenzveig, Roberto H., Pond, Gregory R., Gupta, Sumati V., Wang, Jue, Bilen, Mehmet A., Naik, Gurudatta, Ghatalia, Pooja, Hoimes, Christopher J., Gopalakrishnan, Dharmesh, Barata, Pedro C., Drakaki, Alexandra, Faltas, Bishoy M., Kiedrowski, Lesli A., Lanman, Richard B., Nagy, Rebecca J., Vogelzang, Nicholas J., Boucher, Kenneth M., Vaishampayan, Ulka N., Sonpavde, Guru, Grivas, Petros

Get full text

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells by Boya, Mert, Ozkaya-Ahmadov, Tevhide, Swain, Brandi E., Chu, Chia-Heng, Asmare, Norh, Civelekoglu, Ozgun, Liu, Ruxiu, Lee, Dohwan, Tobia, Sherry, Biliya, Shweta, McDonald, L. DeEtte, Nazha, Bassel, Kucuk, Omer, Sanda, Martin G., Benigno, Benedict B., Moreno, Carlos S., Bilen, Mehmet A., McDonald, John F., Sarioglu, A. Fatih

Get full text

BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis by LEE, Yu-Chen, CHENG, Chien-Jui, BILEN, Mehmet A, LU, Jing-Fang, SATCHER, Robert L, YU-LEE, Li-Yuan, GALLICK, Gary E, MAITY, Sankar N, LIN, Sue-Hwa

Get full text

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma by Abou Alaiwi, Sarah, Xie, Wanling, Nassar, Amin H, Dudani, Shaan, Martini, Dylan, Bakouny, Ziad, Steinharter, John A, Nuzzo, Pier Vitale, Flippot, Ronan, Martinez-Chanza, Nieves, Wei, Xiao, McGregor, Bradley A, Kaymakcalan, Marina D, Heng, Daniel Y C, Bilen, Mehmet A, Choueiri, Toni K, Harshman, Lauren C

Get full text

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort by Barata, Pedro, Hatton, Whitley, Desai, Arpita, Koshkin, Vadim, Jaeger, Ellen, Manogue, Charlotte, Cotogno, Patrick, Light, Malcolm, Lewis, Brian, Layton, Jodi, Sartor, Oliver, Basu, Arnab, Kilari, Deepak, Emamekhoo, Hamid, Bilen, Mehmet A.

Get full text

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood by Carlisle, Jennifer Wilkinson, Jansen, Caroline S, Cardenas, Maria Andrea, Sobierajska, Ewelina, Reyes, Adriana Moon, Greenwald, Rachel, Del Balzo, Luke, Prokhnevska, Nataliya, Kucuk, Omer, Carthon, Bradley C, Mullane, Patrick Connor, Osunkoya, Adeboye, Baumgarten, Deborah, Hosseinzadeh, Fares, Wilkinson, Scott, Lake, Ross, Sowalsky, Adam G, Liu, Yuan, Master, Viraj A, Bilen, Mehmet A, Kissick, Haydn

Get full text

Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma by Kim, Kyu Seo, Sekar, Rishi R., Patil, Dattatraya, Dimarco, Michelle A., Kissick, Haydn T., Bilen, Mehmet A., Osunkoya, Adeboye O., Master, Viraj A.

Get full text

Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carc... by Schmeusser, Benjamin N, Midenberg, Eric, Palacios, Arnold R, Vettikattu, Nikhil, Patil, Dattatraya H, Medline, Alexandra, Higgins, Michelle, Armas-Phan, Manuel, Nabavizadeh, Reza, Joshi, Shreyas S, Narayan, Vikram M, Psutka, Sarah P, Ogan, Kenneth, Bilen, Mehmet A, Master, Viraj A

Get full text

Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis by Patel, Jimmy S, Woo, Yena, Draper, Amber, Jansen, Caroline S, Carlisle, Jennifer W, Innominato, Pasquale F, Lévi, Francis A, Dhabaan, Layla, Master, Viraj A, Bilen, Mehmet A, Khan, Mohammad K, Lowe, Michael C, Kissick, Haydn, Buchwald, Zachary S, Qian, David C

Get full text

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus by Master, Viraj A, Schmeusser, Benjamin N, Osunkoya, Adeboye O, Palacios, Arnold R, Midenberg, Eric, Yantorni, Lauren, Ogan, Kenneth, Bilen, Mehmet A

Get full text

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study by Nagaraj, Gayathri, Vinayak, Shaveta, Khaki, Ali Raza, Sun, Tianyi, Kuderer, Nicole M, Aboulafia, David M, Acoba, Jared D, Awosika, Joy, Bakouny, Ziad, Balmaceda, Nicole B, Bao, Ting, Bashir, Babar, Berg, Stephanie, Bilen, Mehmet A, Bindal, Poorva, Blau, Sibel, Bodin, Brianne E, Borno, Hala T, Castellano, Cecilia, Choi, Horyun, Deeken, John, Desai, Aakash, Edwin, Natasha, Feldman, Lawrence E, Flora, Daniel B, Friese, Christopher R, Galsky, Matthew D, Gonzalez, Cyndi J, Grivas, Petros, Gupta, Shilpa, Haynam, Marcy, Heilman, Hannah, Hershman, Dawn L, Hwang, Clara, Jani, Chinmay, Jhawar, Sachin R, Joshi, Monika, Kaklamani, Virginia, Klein, Elizabeth J, Knox, Natalie, Koshkin, Vadim S, Kulkarni, Amit A, Kwon, Daniel H, Labaki, Chris, Lammers, Philip E, Lathrop, Kate I, Lewis, Mark A, Li, Xuanyi, Lopes, Gilbert de Lima, Lyman, Gary H, Makower, Della F, Mansoor, Abdul-Hai, Markham, Merry-Jennifer, Mashru, Sandeep H, McKay, Rana R, Messing, Ian, Mico, Vasil, Nadkarni, Rajani, Namburi, Swathi, Nguyen, Ryan H, Nonato, Taylor Kristian, O'Connor, Tracey Lynn, Panagiotou, Orestis A, Park, Kyu, Patel, Jaymin M, Patel, Kanishka GopikaBimal, Peppercorn, Jeffrey, Polimera, Hyma, Puc, Matthew, Rao, Yuan James, Razavi, Pedram, Reid, Sonya A, Riess, Jonathan W, Rivera, Donna R, Robson, Mark, Rose, Suzanne J, Russ, Atlantis D, Schapira, Lidia, Shah, Pankil K, Shanahan, M Kelly, Shapiro, Lauren C, Smits, Melissa, Stover, Daniel G, Streckfuss, Mitrianna, Tachiki, Lisa, Thompson, Michael A, Tolaney, Sara M, Weissmann, Lisa B, Wilson, Grace, Wotman, Michael T, Wulff-Burchfield, Elizabeth M, Mishra, Sanjay, French, Benjamin, Warner, Jeremy L, Lustberg, Maryam B, Accordino, Melissa K, Shah, Dimpy P

Get full text

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study by Tannir, Nizar M, Cho, Daniel C, Diab, Adi, Sznol, Mario, Bilen, Mehmet A, Balar, Arjun V, Grignani, Giovanni, Puente, Erika, Tang, Lily, Chien, David, Hoch, Ute, Choudhury, Arkopal, Yu, Danni, Currie, Sue L, Tagliaferri, Mary A, Zalevsky, Jonathan, Siefker-Radtke, Arlene O, Hurwitz, Michael E

Get full text

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A) by Atkins, Michael B, Jegede, Opeyemi A, Haas, Naomi B, Mcdermott, David F, Bilen, Mehmet A, Stein, Mark, Sosman, Jeffrey, Alter, Robert, Plimack, Elizabeth R, Ornstein, Moshe C, Hurwitz, Michael, Peace, David J, Einstein, David, Catalano, Paul J, Hammers, Hans, Regan, Meredith M

Get full text

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B) by Atkins, Michael B, Jegede, Opeyemi A, Haas, Naomi B, McDermott, David F, Bilen, Mehmet A, Stein, Mark, Sosman, Jeffrey A, Alter, Robert, Plimack, Elizabeth R, Ornstein, Moshe C, Hurwitz, Michael, Peace, David J, Signoretti, Sabina, Denize, Thomas, Cimadamore, Alessia, Wu, Catherine J, Braun, David, Einstein, David, Catalano, Paul J, Hammers, Hans

Get full text

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA by Swami, Umang, Zimmerman, Raquel Mae, Nussenzveig, Roberto H, Hernandez, Edgar Javier, Jo, Yeonjung, Sayegh, Nicolas, Wesolowski, Sergiusz, Kiedrowski, Lesli A, Barata, Pedro C, Lemmon, Gordon Howard, Bilen, Mehmet A, Heath, Elisabeth I, Nandagopal, Lakshminarayan, Babiker, Hani M, Pal, Sumanta K, Lilly, Michael, Maughan, Benjamin L, Haaland, Benjamin, Yandell, Mark, Sartor, Oliver, Agarwal, Neeraj

Get full text

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study by Choueiri, Toni K, Shyr, Yu, Grivas, Petros, Thompson, Michael A, Bilen, Mehmet A, Bouganim, Nathaniel, Doroshow, Deborah B, Egan, Pamela C, Elkrief, Arielle, Farmakiotis, Dimitrios, Glover, Michael J, Griffiths, Elizabeth A, Gulati, Anthony P, Gupta, Shilpa, Hsu, Emily, Lemmon, Christopher A, Lewis, Colleen, Masters, Tyler, Mesa, Ruben A, Morgans, Alicia K, Reynolds, Kerry, Rosen, Lane R, Schmidt, Andrew, Shaya, Justin A, Wulff-Burchfield, Elizabeth, Xie, Zhuoer, Yu, Peter P, Zubiri, Leyre, Warner, Jeremy L, Acoba, Jared D., Agarwal, Neeraj, Ahmad, Syed, Ajmera, Archana, Angevine, Anne H., Azad, Nilo, Barnholtz-Sloan, Jill, Barrow, Briana, Boland, Genevieve, Bonnen, Mark, Bouchard, Gabrielle, Busser, Fiona, Casulo, Carla, Curran, Catherine, Deeken, John, Demetri, George D., DiLullo, Sandy, Elias, Rawad, Feldman, Lawrence E., Friese, Christopher R., Fu, Paul, Gillaspie, Erin A., Giordano, Antonio, Glace, (Mary) Grace, Gurley, Michael, Halmos, Balazs, Johnson, Douglas B., Koshkin, Vadim S., Leighton, John C., Li, Xuanyi, LoRusso, Patricia, Low, Clarke A., Mansoor, Abdul-Hai, Handy Marshall, Catherine, Matar, Sara, McNair, Christopher, Mehnert, Janice M., Menon, Harry, Nagle, Sarah, Nakayama, John M., Nelson, Heather H., Nemecek, Eneida R., Nuzzo, Pier Vitale, Oberstein, Paul E., Owenby, Susie, Pasquinelli, Mary M., Revankar, Sanjay G., Rho, Young Soo, Rhodes, Terence D., Rice, Robert L., Riess, Jonathan, Routy, Bertrand, Rovito, Marc A., Saif, M. Wasif, Sanyal, Amit, Serrano, Oscar, Shah, Mansi, Shaw, Grace, Shergill, Ardaman, Stauffer, Karen, Stratton, Jamie, Stratton, Catherine, Subbiah, Vivek, Tannir, Nizar M., Van Allen, Eli, Verma, Amit K., Vikas, Praveen, Weiss, Matthias, Wise-Draper, Trisha, Wood, William A., Zacks, Rosemary

Request full text

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report by Bilen, Mehmet A, Jiang, James F, Jansen, Caroline S, Brown, Jacqueline T, Harik, Lara R, Sekhar, Aarti, Kissick, Haydn, Maithel, Shishir K, Kucuk, Omer, Carthon, Bradley, Master, Viraj A

Get full text

Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers by Barnett, Reagan M., Jang, Albert, Lanka, Sree, Fu, PIngfu, Bucheit, Leslie A., Babiker, Hani, Bryce, Alan, Meyer, Haley M., Choi, Yujin, Moore, Casey, Garje, Rohan, Gao, Xin, Kim, Dae Won, Chang, Richard Y., Gulhati, Pat, Ramaker, Ryne, Bansal, Rani, Zhang, Tian, Oliver Sartor, A., Armstrong, Andrew J., Bilen, Mehmet A., Barata, Pedro

Get full text